Journal of Lipid Research · 2019 · 66 citations · 29 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyInflammationAtherosclerosis PharmacotherapyCardiovascular DiseaseDyslipidemia ManagementLipid ManagementLipid-lowering TherapyLipoprotein MetabolismAtherosclerosis Molecular MechanismsAtherosclerosis-associated MacrophagesAtherosclerotic Disease PreventionAtherosclerotic Plaque RegressionAtherosclerotic ProgressionPlaque InflammationPlaque Morphology AnalysisPlaque Stabilization
< 0.05 vs. baseline), decreased macrophage accumulation through reduced proliferation, and abated lesion severity. Thus, high-intensive cholesterol-lowering triple treatment targeting all apoB-containing lipoproteins regresses atherosclerotic lesion area and improves lesion composition in mice, making it a promising potential approach for treating atherosclerosis.
29